Bioavailability is used to determine

Pneumonic: ARDR 1 amount of drug absorbed from a formulation or dosage form 2 rate at which the drug was absorbed 3 duration of the drug's presence in biologic fluid or tissue correlated with the patient's response, and 4 relationship between drug blood levels and clinical efficacy and toxicity.